ArticleNeuro-oncology2015
End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.
Warren P MasonPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it